Functional activity of nonspecific T-lymphocyte suppressors in health persons and in systemic lupus erythematosus patients
Drannik, G.N.; Lysenko, G.I.; Montag, T.S.; Kozlovskaia, I.N.; Litvishchenko, E.I.
Vrachebnoe Delo 1: 88-90
1980
ISSN/ISBN: 0049-6804 PMID: 6445651 Document Number: 165722
Document emailed within 1 workday
Related Documents
Benenson, E.V.; Tsaĭ, E.G. 1990: The rapid cytofluorometric indices of lymphocyte functional activity in rheumatoid arthritis and systemic lupus erythematosus Terapevticheskii Arkhiv 62(5): 22-27Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Ljaljević, M.; Ljaljević, J.; Kunosić, J.; Zlatković, L. 1985: The level of the T lymphocyte and B lymphocyte subpopulations in patients with systemic lupus erythematosus Glas. Srpska Akademija Nauka i Umetnosti. Odeljenje Medicinskih Nauka 37: 131-139
Becker, H.; Schauer, U.; Helmke, K. 1986: B lymphocyte activation by insoluble anti-mu antibodies in patients with systemic lupus erythematosus Clinical and Experimental Immunology 66(2): 365-372
Nesterenko, G.B.; Kogon, G.K.; Bashmakov, G.V.; Ploskaia, L.M.; Didenko, I.G. 1981: Nonspecific defense mechanisms and immune responsiveness in patients with eczema, systemic lupus erythematosus, psoriasis and dermatitis medicamentosa Vestnik Dermatologii i Venerologii 3: 21-24
Turner-Stokes, L.; Cambridge, G.; Snaith, M.L. 1989: In vitro lymph node and peripheral blood lymphocyte responses to influenza immunization in patients with systemic lupus erythematosus Clinical and Experimental Rheumatology 7(1): 71-74
Greco, C.M.; Rudy, T.E.; Manzi, S. 2004: Effects of disease activity, pain, and distress on activity limitations in patients with systemic lupus erythematosus Journal of Rheumatology 31(2): 260-267
Sutcliffe, N.; Stoll, T.; Pyke, S.; Isenberg, D.A. 1998: Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS Journal of Rheumatology 25(1): 63-68
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
D'Cruz, D.P.; Mellor-Pita, S.; Joven, B.; Sanna, G.; Allanson, J.; Taylor, J.; Khamashta, M.A.; Hughes, G.R.V. 2004: Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies Journal of Rheumatology 31(2): 280-285
Witt, C.; Neuhaus, K.; Winsel, K.; Brenke, A.; Hiepe, F.; Volk, H.D. 1991: Bronchoalveolar lavage in patients with systemic scleroderma and systemic lupus erythematosus: characterization of cell activity by cytofluorometry, chemiluminescence and differential cell count Zeitschrift für Erkrankungen der Atmungsorgane 176(1): 21-29
Frizen, B.N.; Zhegin, V.A. 1976: Clinico-functional characteristics of the esophagus in rheumatoid arthritis and systemic lupus erythematosus in comparison with systemic scleroderma Terapevticheskii Arkhiv 48(11): 57-64
Diumenjo, M.S.; Rivero, I.; Vannucci, J.D. 1978: Nonspecific defense mechanism in systemic lupus erythematosus: phagocytosis, adherence and leukocyte peroxidase Revista Clinica Espanola 148(3): 273-277
Kurosaka, D.; Yasuda, J.; Yoshida, K.; Yoneda, A.; Yasuda, C.; Kingetsu, I.; Toyokawa, Y.; Yokoyama, T.; Saito, S.; Yamada, A. 2006: Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus Journal of Rheumatology 33(6): 1102-1107
Tomii, M. 1981: Anti-DNA activity in Raji cell eluates of sera from patients with systemic lupus erythematosus Ryumachi 21 Suppl: 123-127
Kohno, Y.; Naito, N.; Saito, K.; Hoshioka, A.; Niimi, H.; Nakajima, H.; Hosoya, T. 1989: Anti-thyroid peroxidase antibody activity in sera of patients with systemic lupus erythematosus Clinical and Experimental Immunology 75(2): 217-221
Miyoshi, Y.; Kilpatrick, K.A.; Kelley, R.O.; Searles, R.P.; Williams, R.C. 1985: Antibodies to lymphocyte membrane preparations in systemic lupus erythematosus Journal of Rheumatology 12(6): 1097-1104
Hara, M. 1977: Clinical significance of the lymphocyte function in systemic lupus erythematosus Ryumachi 17(1): 6-16
Lu, M.-C.; Lai, N.-S.; Li, K.-J.; Hsieh, S.-C.; Wu, C.-H.; Yu, C.-L. 2008: Increased multidrug resistance-associated protein activity in mononuclear cells of patients with systemic lupus erythematosus Clinical and Experimental Rheumatology 26(4): 638-645
Bi, L.Q.; Song, Y.; Sun, R.W. 1990: Lymphocyte phenotypes and their correlation with clinical features in systemic lupus erythematosus (SLE) Zhonghua Nei Ke Za Zhi 29(12): 720